Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 182

    1.

    A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA)

    Forman J, Moline J, Cernichiari E, Sayegh S, Torres JC, Landrigan MM, Hudson J, Adel HN, Landrigan PJ.

    Environ Health Perspect. 2000 Jun;108(6):575-7.PMID: 10856034 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA).

    Roels HA, Boeckx M, Ceulemans E, Lauwerys RR.

    Br J Ind Med. 1991 Apr;48(4):247-53.PMID: 1851035 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.

    Counter SA, Ortega F, Shannon MW, Buchanan LH.

    Int J Occup Environ Health. 2003 Apr-Jun;9(2):164-8.PMID: 12848245 [PubMed - indexed for MEDLINE]Related articles

    4.

    Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.

    Ruha AM, Curry SC, Gerkin RD, Caldwell KL, Osterloh JD, Wax PM.

    Arch Pathol Lab Med. 2009 Jan;133(1):87-92.PMID: 19123743 [PubMed - indexed for MEDLINE]Related articles

    5.

    Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.

    Graziano JH, Lolacono NJ, Moulton T, Mitchell ME, Slavkovich V, Zarate C.

    J Pediatr. 1992 Jan;120(1):133-9.PMID: 1309865 [PubMed - indexed for MEDLINE]Related articles

    6.

    Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.

    Besunder JB, Anderson RL, Super DM.

    Pediatrics. 1995 Oct;96(4 Pt 1):683-7.PMID: 7567330 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.

    Torres-Alanís O, Garza-Ocañas L, Piñeyro-López A.

    Hum Exp Toxicol. 2002 Nov;21(11):573-7.PMID: 12507251 [PubMed - indexed for MEDLINE]Related articles

    8.

    Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.

    Chisolm JJ Jr.

    J Toxicol Clin Toxicol. 2000;38(4):365-75.PMID: 10930052 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.

    Kostial K, Restek-Samarzija N, Blanusa M, Piasek M, Jones MM, Singh PK.

    Pharmacol Toxicol. 1997 Nov;81(5):242-4.PMID: 9396091 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.

    Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL; Treatment of Lead-Exposed Children Clinical Trial Group.

    Pediatrics. 2004 Jul;114(1):19-26.PMID: 15231903 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.

    Flora SJ, Mehta A, Rao PV, Kannan GM, Bhaskar AS, Dube SN, Pant BP.

    Toxicology. 2004 Feb 15;195(2-3):127-46.PMID: 14751669 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.

    Smith D, Bayer L, Strupp BJ.

    Environ Res. 1998 Aug;78(2):168-76.PMID: 9719621 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure?

    Frumkin H, Manning CC, Williams PL, Sanders A, Taylor BB, Pierce M, Elon L, Hertzberg VS.

    Environ Health Perspect. 2001 Feb;109(2):167-71.PMID: 11266328 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.

    Glotzer DE.

    Drug Saf. 1993 Aug;9(2):85-92. Review.PMID: 8397892 [PubMed - indexed for MEDLINE]Related articles

    15.

    Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.

    Kostial K, Restek-Samarzija N, Blanusa M, Piasek M, Prester L, Jones MM, Singh PK.

    J Appl Toxicol. 1997 Jan-Feb;17(1):71-4.PMID: 9048230 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.

    Hoogesteijn AL, Raphael BL, Calle P, Cook R, Kollias G.

    J Zoo Wildl Med. 2003 Mar;34(1):82-7.PMID: 12723805 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mercury intoxication in a 2-year-old girl: a diagnostic challenge for the physician.

    Michaeli-Yossef Y, Berkovitch M, Goldman M.

    Pediatr Nephrol. 2007 Jun;22(6):903-6. Epub 2007 Feb 20.PMID: 17310361 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.

    Muran PJ.

    Altern Ther Health Med. 2006 May-Jun;12(3):70-5.PMID: 16708769 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.

    Cremin JD Jr, Luck ML, Laughlin NK, Smith DR.

    Environ Health Perspect. 2001 Jun;109(6):613-9.PMID: 11445516 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.

    Cremin JD Jr, Luck ML, Laughlin NK, Smith DR.

    Toxicol Appl Pharmacol. 1999 Dec 15;161(3):283-93.PMID: 10620486 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data